The Joint Commission's stated industry best practice for standard communication is known as:

A. Method is not one of the recognized 10 rights of safe medication administration. It is important to follow the correct method, but it is encompassed by the rights such as the right route and right time.
B. Unit is not part of the 10 rights of safe medication administration. Accurate dosage units are critical but are covered under the right dose and right medication.
C. The right medication ensures that the patient receives the correct drug, reducing the risk of adverse effects and therapeutic failures. Verifying the right medication is fundamental to safe medication administration practices.
D. The right evaluation involves monitoring the patient’s response to the medication to ensure it is effective and safe. This step helps in identifying any adverse reactions or the need for dosage adjustments.
E. The right assessment involves evaluating the patient’s condition before administering medication to determine if it is appropriate. It ensures that the medication is given safely, considering the patient’s current health status.
F. The right to client education involves informing the patient about the medication they are receiving, including its purpose, potential side effects, and any special instructions. Educating the patient promotes adherence and helps in the early identification of adverse effects.

A. Anemia is not a common adverse effect of atenolol, a beta-blocker primarily affecting heart rate and blood pressure.
B. Bradycardia (slow heart rate) is a known adverse effect of atenolol due to its action of slowing the heart rate to manage hypertension and other cardiac conditions.
C. Neutropenia (low neutrophil count) is not typically associated with atenolol use.
D. Hypokalemia (low potassium levels) is not a common adverse effect of atenolol; electrolyte imbalances are more associated with diuretics.